Search research articles
Contact Us
Filters
Showing results (71-80 of 79) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 79 results.
Rheumatology (Oxford, England)
|
November 3, 2021
An enhanced mitochondrial function through glutamine metabolism in plasmablast differentiation in systemic lupus erythematosus
Maiko Hajime Sumikawa, Shigeru Iwata, Mingzeng Zhang, et al.
Rheumatology (Oxford, England)
|
March 11, 2021
Pathological role of activated mTOR in CXCR3+ memory B cells of rheumatoid arthritis
Shigeru Iwata, Mingzeng Zhang, Maiko Hajime, et al.
Diabetes & Metabolism
|
April 28, 2023
Effect of ipragliflozin on endothelial dysfunction in patients with type 2 diabetes and chronic kidney disease: A randomized clinical trial (PROCEED)
Atsushi Tanaka, Yosuke Okada, Keiichi Torimoto, et al.
American Journal of Physiology. Cell Physiology
|
November 24, 2021
Glucose consumption of vascular cell types in culture: toward optimization of experimental conditions
Keiichi Torimoto, Keisuke Okuno, Ryohei Kuroda, et al.
Cardiovascular Diabetology
|
January 5, 2021
Effect of tofogliflozin on arterial stiffness in patients with type 2 diabetes: prespecified sub-analysis of the prospective, randomized, open-label, parallel-group comparative UTOPIA trial
Naoto Katakami, Tomoya Mita, Hidenori Yoshii, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
August 6, 2021
The Influence of Tofogliflozin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus
Naoto Katakami, Tomoya Mita, Hidenori Yoshii, et al.
Cardiovascular Diabetology
|
July 11, 2020
Tofogliflozin does not delay progression of carotid atherosclerosis in patients with type 2 diabetes: a prospective, randomized, open-label, parallel-group comparative study
Naoto Katakami, Tomoya Mita, Hidenori Yoshii, et al.
Kidney International Reports
|
May 25, 2026
Randomized Trial of Finerenone on Urinary Albumin-to-Creatinine Ratio in Type 2 Diabetes Mellitus and CKD
Atsushi Tanaka, Takumi Imai, Muthiah Vaduganathan, et al.
Cardiovascular Diabetology
|
December 5, 2025
Effects of finerenone on arterial stiffness and cardiorenal biomarkers in patients with type 2 diabetes and chronic kidney disease: a randomised placebo-controlled mechanistic trial (FIVE-STAR)
Atsushi Tanaka, Muthiah Vaduganathan, Takumi Imai, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 79) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 79 results.
Rheumatology (Oxford, England)
|
November 3, 2021
An enhanced mitochondrial function through glutamine metabolism in plasmablast differentiation in systemic lupus erythematosus
Maiko Hajime Sumikawa, Shigeru Iwata, Mingzeng Zhang, et al.
Rheumatology (Oxford, England)
|
March 11, 2021
Pathological role of activated mTOR in CXCR3+ memory B cells of rheumatoid arthritis
Shigeru Iwata, Mingzeng Zhang, Maiko Hajime, et al.
Diabetes & Metabolism
|
April 28, 2023
Effect of ipragliflozin on endothelial dysfunction in patients with type 2 diabetes and chronic kidney disease: A randomized clinical trial (PROCEED)
Atsushi Tanaka, Yosuke Okada, Keiichi Torimoto, et al.
American Journal of Physiology. Cell Physiology
|
November 24, 2021
Glucose consumption of vascular cell types in culture: toward optimization of experimental conditions
Keiichi Torimoto, Keisuke Okuno, Ryohei Kuroda, et al.
Cardiovascular Diabetology
|
January 5, 2021
Effect of tofogliflozin on arterial stiffness in patients with type 2 diabetes: prespecified sub-analysis of the prospective, randomized, open-label, parallel-group comparative UTOPIA trial
Naoto Katakami, Tomoya Mita, Hidenori Yoshii, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
August 6, 2021
The Influence of Tofogliflozin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus
Naoto Katakami, Tomoya Mita, Hidenori Yoshii, et al.
Cardiovascular Diabetology
|
July 11, 2020
Tofogliflozin does not delay progression of carotid atherosclerosis in patients with type 2 diabetes: a prospective, randomized, open-label, parallel-group comparative study
Naoto Katakami, Tomoya Mita, Hidenori Yoshii, et al.
Kidney International Reports
|
May 25, 2026
Randomized Trial of Finerenone on Urinary Albumin-to-Creatinine Ratio in Type 2 Diabetes Mellitus and CKD
Atsushi Tanaka, Takumi Imai, Muthiah Vaduganathan, et al.
Cardiovascular Diabetology
|
December 5, 2025
Effects of finerenone on arterial stiffness and cardiorenal biomarkers in patients with type 2 diabetes and chronic kidney disease: a randomised placebo-controlled mechanistic trial (FIVE-STAR)
Atsushi Tanaka, Muthiah Vaduganathan, Takumi Imai, et al.
Page
of 8